Vitro Biopharma, Inc. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 01/31/24 Q1

ended 10/31/23 FY 2023

ended 07/31/23 Q3

ended 04/30/23 Q2

ended 01/31/23 Q1

Prospectuses and Registrations Filter

Initial registration of new securities – amended

Initial registration of new securities – amended

Exempt offering of securities

Initial registration of new securities – amended

Registration of securities on exchange

Ownership Filter

Furman Christopher

Furman Christopher

News Filter

Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement, Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement, Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Announces New Chief Financial Officer

Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement, Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement, Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Proxies Filter

Definitive proxy

Preliminary proxy

Preliminary proxy

Definitive proxy

Preliminary proxy

Other Filter

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC